UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab

Clinical and experimental immunology, 2021-01, Vol.203 (1), p.96-104

2021

Volltextzugriff (PDF)

Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors

Bone marrow transplantation (Basingstoke), 2017-12, Vol.52 (12), p.1643-1650

2017

Volltextzugriff (PDF)

Against the odds: haplo-cord grafts protect from GvHD and relapse

Bone marrow transplantation (Basingstoke), 2017-12, Vol.52 (12), p.1590-1591

2017

Volltextzugriff (PDF)

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804

Annals of oncology, 2007-06, Vol.18 (6), p.1071-1079

2007

Volltextzugriff (PDF)

Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1342-1349

2016

Volltextzugriff (PDF)

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma

Blood, 2003-11, Vol.102 (10), p.3521-3529

2003

Volltextzugriff (PDF)

Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.217-226

2012

Volltextzugriff (PDF)

A strategy to reduce donor-specific HLA Abs before allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.722-724

2014

Volltextzugriff (PDF)

Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients

Haematologica (Roma), 2014-08, Vol.99 (8), p.1373

2014

Volltextzugriff (PDF)

Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance

Bone marrow transplantation (Basingstoke), 2008-03, Vol.41 (6), p.505-513

2008

Volltextzugriff (PDF)

Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis

Bone marrow transplantation (Basingstoke), 2012-11, Vol.47 (11), p.1455-1458

2012

Volltextzugriff (PDF)

Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML

Bone marrow transplantation (Basingstoke), 2010-12, Vol.45 (12), p.1692-1698

2010

Volltextzugriff (PDF)

A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1437-1443

2013

Volltextzugriff (PDF)

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2010-06, Vol.45 (6), p.1068-1076

2010

Volltextzugriff (PDF)

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2007-12, Vol.40 (11), p.1027-1032

2007

Volltextzugriff (PDF)

Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients

Bone marrow transplantation (Basingstoke), 2015-09, Vol.50 (9), p.1227-1234

2015

Volltextzugriff (PDF)

Allogeneic Blood Stem Cell Transplantation for Refractory Leukemia and Lymphoma: Potential Advantage of Blood Over Marrow Allografts

Blood, 1995-03, Vol.85 (6), p.1659-1665

1995

Volltextzugriff (PDF)

Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes

Bone marrow transplantation (Basingstoke), 2005-05, Vol.35 (10), p.965-970

2005

Volltextzugriff (PDF)

Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning

Bone marrow transplantation (Basingstoke), 2006-02, Vol.37 (3), p.307-310

2006

Volltextzugriff (PDF)

Management of lymphoma recurrence after allogeneic transplantation : the relevance of graft-versus-lymphoma effect

Bone marrow transplantation (Basingstoke), 1997-05, Vol.19 (10), p.977-982

1997

Volltextzugriff (PDF)

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

Bone marrow transplantation (Basingstoke), 2001-02, Vol.27 (4), p.387-396

2001

Volltextzugriff (PDF)

Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience

Bone marrow transplantation (Basingstoke), 2005-02, Vol.35 (3), p.253-260

2005

Volltextzugriff (PDF)

Severe intestinal graft-versus-host disease following autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2006-09, Vol.38 (5), p.391-392

2006

Volltextzugriff (PDF)

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

Bone marrow transplantation (Basingstoke), 2004-05, Vol.33 (10), p.1015-1023

2004

Volltextzugriff (PDF)

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease

Bone marrow transplantation (Basingstoke), 2000-08, Vol.26 (4), p.445-449

2000

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(208)
Mit Volltextzugriff
(228)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(154)
Humans
(149)
Life Sciences & Biomedicine
(146)
Adult
(111)
Female
(107)
Hematology
(103)
Middle Aged
(102)
Male
(95)
Biological And Medical Sciences
(88)
Medical Sciences
(86)
Oncology
(78)
Immunology
(56)
Transplantation
(55)
Adolescent
(46)
Transplantation, Homologous
(46)
Anesthesia. Intensive Care Medicine. Transfusions. Cell Therapy And Gene Therapy
(45)
Transfusions. Complications. Transfusion Reactions. Cell And Gene Therapy
(45)
Bone Marrow, Stem Cells Transplantation. Graft Versus Host Reaction
(43)
Treatment Outcome
(43)
Aged
(42)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MASP2 levels are elevated in thrombotic microangiopathies: association with microvascular endothelial cell injury and suppression by anti‐MASP2 antibody narsoplimab

Associations between acute gastrointestinal GvHD and the baseline gut microbiota of allogeneic hematopoietic stem cell transplant recipients and donors

Against the odds: haplo-cord grafts protect from GvHD and relapse

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804

Identification of high-risk amino-acid substitutions in hematopoietic cell transplantation: a challenging task

Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma

Identification by random forest method of HLA class I amino acid substitutions associated with lower survival at day 100 in unrelated donor hematopoietic cell transplantation

A strategy to reduce donor-specific HLA Abs before allogeneic transplantation

Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients

Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance

Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis

Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML

A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation

Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation

Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients

Allogeneic Blood Stem Cell Transplantation for Refractory Leukemia and Lymphoma: Potential Advantage of Blood Over Marrow Allografts

Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes

Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning

Management of lymphoma recurrence after allogeneic transplantation : the relevance of graft-versus-lymphoma effect

Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR)

Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience

Severe intestinal graft-versus-host disease following autologous stem cell transplantation

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease

Suchergebnisse filtern